Acrux
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAAcrux Limited (ACR) is an Australian drug delivery company dedicated to developing and commercialising topical pharmaceuticals products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including Testosterone Solution and Estradiol MDTS.
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 481st | Acrux | 29% | -25% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Acrux | $8.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Donald Brumley, Non-Executive Director | 03 Jul 2024 |
| NEWS: Tagged in Regeneus trebles on back of merger deal | 05 Apr 2024 |
| NEW ROLE: Mark Hyman, | 01 Mar 2022 |
| NEW ROLE: Nina Webster, Commercial Director | 24 Nov 2020 |
| NEW ROLE: Tim Bateman, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: Felicia Colagrande, Product Development and Technical Affairs Director | 24 Nov 2020 |
| NEW ROLE: Charles O'Sullivan, Portfolio Directorá | 24 Nov 2020 |
| NEW ROLE: Norman Gray, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Deborah Ambrosini, Chief Financial Officer, Company Secretary | 03 Nov 2020 |
